7 recruiting. 7 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 7 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Multiple System Atrophy: new trials by email Literature Review of Multiple System Atrophy trials Research Report on Multiple System Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial Tributyrin, Placebo - Parkinson Disease, Multiple System Atrophy | Phase 1 / Phase 2 | Recruiting | Prabesh Kanel | 15 | 2026-10-01 | 2026-11-05 |
| Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy 3-N-butylphthalide - Multiple System Atrophy | Phase 2 / Phase 3 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 150 | 2026-08-27 | 2026-10-16 |
| An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy TEV-56286 - Multiple System Atrophy | Phase 2 | Recruiting | Teva Branded Pharmaceutical Products R&D LLC | 200 | 2025-09-30 | 2026-10-09 |
| Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease. Administration of Carbidopa/levodopa - Multi-system Atrophy - Parkinsonian Type, Orthostatic Hypotension, Dysautonomic | Phase 1 / Phase 2 | Recruiting | Julien Bally | 36 | 2025-07-18 | 2026-01-29 |
| A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA) Foralumab Nasal - Multiple System Atrophy | Phase 2 | Recruiting | Tiziana Life Sciences LTD | 5 | 2025-05-19 | 2026-06-10 |
| The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism Nicotinamide Riboside, Placebo - Progressive Supranuclear Palsy, Multiple System Atrophy | Phase 2 | Recruiting | Haukeland University Hospital | 330 | 2024-03-05 | 2025-01-10 |
| [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD [18F]-MFBG PET CT, [18F]-FE-PE2I PET CT or PET MRI, [123I]-MIBG SPECT CT - Parkinson Disease, Dementia With Lewy Bodies | Phase 2 / Phase 3 | Recruiting | prof. dr. Koen Van Laere | 113 | 2024-01-19 | 2025-02-06 |
Parkinson Disease (3) · Shy-Drager Syndrome (2) · Supranuclear Palsy, Progressive (2) · Alzheimer Disease (1) · Corticobasal Degeneration (1) · Dementia (1) · Lewy Body Disease (1) · Movement Disorders (1) · Parkinsonian Disorders (1) · Primary Dysautonomias (1)
Autonomic Nervous System Diseases (7) · Basal Ganglia Diseases (7) · Brain Diseases (7) · Central Nervous System Diseases (7) · Nervous System Diseases (7) · Neurodegenerative Diseases (7) · Synucleinopathies (7) · Movement Disorders (6) · Primary Dysautonomias (6) · Tauopathies (3) · Cardiovascular Diseases (2) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Hypotension (2)
3-n-butylphthalide (1) · Levodopa (1) · nicotinamide-beta-riboside (1) · tributyrin (1)
Haukeland University Hospital (1) · Julien Bally (1) · Prabesh Kanel (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Teva Branded Pharmaceutical Products R&D LLC (1) · Tiziana Life Sciences LTD (1) · prof. dr. Koen Van Laere (1)
United States (3) · Belgium (1) · China (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Norway (1) · Spain (1) · Switzerland (1)
Charalampos Tzoulis, MD, PhD (1) · Jiali Pu, MD (1) · Koen Van Laere (1) · Prabesh Kanel, PhD (1)
2023 (1), 2025 (1)